Omega Fund VI, L.P. 13D and 13G filings for Ikena Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-02-14 4:48 pm Unchanged | 2023-12-31 | 13G | Ikena Oncology, Inc. IKNA | Omega Fund VI, L.P. | 2,249,123 4.700% | 0 (Unchanged) | Filing |
2022-02-14 2:57 pm Purchase | 2021-12-31 | 13G | Ikena Oncology, Inc. IKNA | Omega Fund VI, L.P. | 2,249,123 6.300% | 2,249,123![]() (New Position) | Filing |